AQST FY 2025 Earnings — Aquestive Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

AQSTAquestive Therapeutics, Inc.

$431M

FY 2025 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$45M-22.6% YoY

Gross Profit

-$16M-35.0% margin

Operating Income

-$71M-159.5% margin

Net Income

-$84M-188.1% margin

EPS (Diluted)

$-0.76

Cash Flow

Operating Cash Flow

-$52M

Free Cash Flow

-$53M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$160M

Total Liabilities

$194M

Stockholders' Equity

-$34M

Cash & Equivalents

$121M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$45M	$58M	-22.6%
Gross Profit	-$16M	$40M	-139.3%
Operating Income	-$71M	-$31M	-130.9%
Net Income	-$84M	-$44M	-89.8%